Wesley Wilson, PhD, a postdoctoral researcher, has been acknowledged as a 2021 "40 Under 40 in Cancer." The award recognizes contributions being made across the field of cancer by rising stars and emerging leaders under the age of 40. Wilson has been working in cancer research for more than a decade with a focus on developing new therapies for hard-to-treat diseases like childhood brain tumors, adult mesothelioma, and multiple myeloma, the latter of which he is studying at Penn using CAR T-cell therapy. His specialties include focusing on modulation of the immune response to cancer using a variety of tools and technologies to characterize the cancer immune response and then leveraging cutting-edge immunotherapies such as checkpoint blockade immunotherapy and CAR-T cell therapy to continue to deliver improved responses for patients. In receiving the award, Wilson was recognized as one of the nation's most promising young oncology professionals whose contributions have helped to improve the lives of those affected by cancer.
